Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2001;104:1407-1412
doi: 10.1161/hc3701.095583
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyata, M.
Right arrow Articles by Tei, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyata, M.
Right arrow Articles by Tei, C.
Related Collections
Right arrow Restenosis
Right arrow Gene expression
Right arrow Smooth muscle proliferation and differentiation

(Circulation. 2001;104:1407.)
© 2001 American Heart Association, Inc.


Basic Science Reports

Apolipoprotein J/Clusterin Is Induced in Vascular Smooth Muscle Cells After Vascular Injury

Masaaki Miyata, MD, PhD; Sadatoshi Biro, MD, PhD; Hiroshi Kaieda, MD, PhD; Hideyuki Eto, MD; Koji Orihara, MD; Takashi Kihara, MD; Hachiro Obata, MD, PhD; Noriko Matsushita, PhD; Takami Matsuyama, MD, PhD; Chuwa Tei, MD, PhD

From the First Department of Internal Medicine (M.M., S.B., H.K., H.E., K.O., T.K., H.O., C.T.) and Medical Zoology and Immunology (N.M., T.M.), Faculty of Medicine, Kagoshima University, Kagoshima, Japan.

Correspondence to Sadatoshi Biro, MD, PhD, First Department of Internal Medicine, Faculty of Medicine, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima 890-8520, Japan. E-mail biro{at}m2.kufm.kagoshima-u.ac.jp

Background— Understanding the precise molecular mechanisms underlying the phenomenon of restenosis after PTCA may help us to develop a new strategy for the treatment of restenosis after PTCA. The purpose of this study was to identify the genes involved in vascular restenosis.

Methods and Results— Applying a differential hybridization method to a model of the balloon-injured rabbit aorta, we identified 6 cDNA clones that were upregulated after injury. Northern blot showed that 5 genes, but not apolipoprotein J (apoJ)/clusterin, were constitutively expressed in noninjured aorta and upregulated after balloon injury. ApoJ mRNA was not detectable in noninjured aorta (control), began to be expressed at 6 hours after injury, showed a peak level at 24 hours (a 48-fold increase), gradually declined, and returned to the control level at 24 weeks. Western blot and immunohistochemistry demonstrated no expression of apoJ protein in noninjured aorta, an expression of apoJ at 2 days after balloon injury, and a peak level (a 55-fold increase) at 2 to 8 weeks. The expression of apoJ protein continued until 24 weeks after injury. In situ hybridization revealed that apoJ mRNA was expressed in smooth muscle cells (SMCs) of media at 2 days after injury and in SMCs of media and neointima at 2 weeks. To analyze the function of apoJ, stably transfected rabbit SMCs were created. The expression of apoJ stimulated proliferation and migration of SMCs.

Conclusions— ApoJ is dramatically induced in media and neointima after vascular injury, suggesting that apoJ contributes to restenosis after angioplasty.


Key Words: angioplasty • restenosis • muscle, smooth • apolipoproteins




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. A. J. Krijnen, S. A. G. M. Cillessen, R. Manoe, A. Muller, C. A. Visser, C. J. L. M. Meijer, R. J. P. Musters, C. E. Hack, L. A. Aarden, and H. W. M. Niessen
Clusterin: a protective mediator for ischemic cardiomyocytes?
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2193 - H2202.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
L. Anderson
Candidate-based proteomics in the search for biomarkers of cardiovascular disease
J. Physiol., February 15, 2005; 563(1): 23 - 60.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Orlandi, S. Pucci, A. Ciucci, F. Pichiorri, A. Ferlosio, and L. G. Spagnoli
Modulation of Clusterin Isoforms Is Associated With All-Trans Retinoic Acid-Induced Proliferative Arrest and Apoptosis of Intimal Smooth Muscle Cells
Arterioscler. Thromb. Vasc. Biol., February 1, 2005; 25(2): 348 - 353.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
W. C.Y. Leung, A. Lawrie, S. Demaries, H. Massaeli, A. Burry, S. Yablonsky, J. M. Sarjeant, E. Fera, E. Rassart, J. G. Pickering, et al.
Apolipoprotein D and Platelet-Derived Growth Factor-BB Synergism Mediates Vascular Smooth Muscle Cell Migration
Circ. Res., July 23, 2004; 95(2): 179 - 186.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Eto, S. Biro, M. Miyata, H. Kaieda, H. Obata, T. Kihara, K. Orihara, and C. Tei
Angiotensin II type 1 receptor participates in extracellular matrix production in the late stage of remodeling after vascular injury
Cardiovasc Res, July 1, 2003; 59(1): 200 - 211.
[Abstract] [Full Text] [PDF]